Alveon

The future of metered inhalation

With a singular setup of patent pending technology, medical expertise in inhalation and access to decades of pharma experience, ALVEON becomes the stepping stone in the future of the Medical Cannabis Market. We are developing the next generation of smart dose vaporizers (SDV1) specifically designed for the precise, controlled inhalation of medical liquid cannabinoids (e.g., THC/CBD). Our mission is to transform patient care by eliminating the dosing variability and compliance risks associated with current-generation devices.